Chapter 17: Immunologic System Medications

Core Principles of the Immune Response and Inflammation

  • Immune Response Function and Overview

    • The immune response is the physiological mechanism by which the body identifies, neutralizes, and defends itself against pathogenic microorganisms, such as bacteria, viruses, fungi, and parasites.
    • It maintains biological integrity by distinguishing self-antigens from non-self, foreign entities.

  • Antigen Characteristics

    • An antigen is defined as any substance that the immune system recognizes as foreign and capable of eliciting an immune reaction.
    • Examples include unique surface proteins, lipoproteins, or polysaccharides found on the outer membranes of bacteria and the envelopes or capsids of viruses.

  • Inflammatory Response Dynamics

    • Inflammation represents the body's immediate, localized, protective response to physical trauma, biological infection, or chemical irritation.
    • Its biological purpose is to contain the injury, destroy invading pathogens, clear out necrotic tissue, and initiate tissue repair and healing.
    • The five cardinal signs of acute inflammation are:
    • Redness (rubor): Resulting from localized vasodilation and increased microvascular perfusion.
    • Swelling (tumor): Caused by increased capillary permeability leading to fluid and protein exudation into the interstitial space.
    • Heat (calor): Driven by enhanced blood flow carrying core thermal energy to peripheral tissues.
    • Pain (dolor): Mediated by tissue distortion from edema and chemical stimulation of nociceptors by inflammatory mediators (e.g., prostaglandins, bradykinin, histamine).
    • Loss of function (functio laesa): Induced by severe tumefaction, reflex muscle inhibition, and structural tissue disruption.
    • Clinical Scenario: When a patient sustains a digital laceration (cuts a finger), the affected perimeter rapidly turns erythematous, warm to touch, edematous, and tender due to rapid inflammatory mediator cascade release.

  • Humoral Immunity and Antibodies

    • Antibodies (immunoglobulins) are specialized gamma-globulin proteins synthesized and secreted by differentiated B lymphocytes, specifically known as plasma cells.
    • Antibodies recognize, bind with high affinity, and neutralize specific antigenic epitopes, tagging pathogens for destruction via phagocytosis or complement activation.
    • Example: Following the administration of an active vaccine, the recipient's plasma cells generate specific neutralizing antibodies that establish lasting immunity against future exposures.

  • Autoimmunity and Pathophysiological Manifestations

    • Autoimmune disorders develop when the immune system experiences a failure of self-tolerance, mistakenly identifying native healthy host cells, tissues, and organs as foreign and mounting a destructive immune assault.
    • Clinical Manifestations and Examples:
    • Rheumatoid Arthritis: Chronic systemic autoimmune targeting of synovial joint linings, leading to chronic synovitis, cartilage destruction, pain, and articular deformities.
    • Type 1 Diabetes Mellitus: T-cell-mediated destruction of insulin-producing beta cells in the pancreatic islets of Langerhans, eliminating endogenous insulin production.
    • Systemic Lupus Erythematosus (Lupus): Widespread autoantibody production forming immune complexes that deposit across multiple organ systems, triggering damage in the kidneys, joints, skin, heart, and central nervous system.

  • Step-by-Step Progression of the Immune Response

    1. Pathogen Ingress: A microbial pathogen (bacterial cell or viral virion) breaches primary protective anatomical barriers, entering the body through epithelial defects in the skin, respiratory mucosa, oral cavity, or other bodily orifices.
    2. Antigen Recognition: Specialized sentinel cells identify distinct antigenic surface markers on the microbe as foreign non-self molecules.
    3. Inflammatory Initiation: Endothelial cells and resident mast cells release vascular mediators, initiating local vasodilation and microvascular leakage; the region becomes swollen, erythematous, warm, and painful as immune cells home toward the site.
    4. Leukocyte Mobilization and Attack: Phagocytic white blood cells (neutrophils and macrophages) migrate into the affected tissue to engulf and digest pathogens; concomitantly, activated B lymphocytes differentiate into plasma cells to manufacture antigen-specific antibodies.
    5. Memory Formation: Following pathogen clearance, a subpopulation of antigen-primed lymphocytes differentiates into long-lived memory B and memory T cells, conferring the ability to launch an immediate, amplified secondary immune response upon subsequent pathogen re-exposure.

Classifications of Immunity and Immunization

  • Natural Immunity

    • Natural immunity denotes innate, non-specific protection acquired across evolutionary time scales, providing foundational, species-wide resistance against specific biological threats without prior individualized exposure.

  • Acquired Immunity Classifications

    • Active Natural Immunity
    • Generated when an individual is naturally exposed to an infectious microbe in the environment; the host survives the clinical or subclinical infection, and the host's immune system actively synthesizes endogenous antibodies and memory cells.
    • Passive Natural Immunity
    • Conferred through the physiological transfer of preformed maternal antibodies across the placental barrier into the developing fetus during gestation, or via colostrum and breast milk during postpartum lactation.
    • Provides immediate but temporary protective coverage in the neonate, generally persisting for a duration of 3 to 6 months3\text{ to }6\text{ months}.
    • Active Artificial Immunity
    • Induced by the clinical administration of a vaccine containing attenuated living microbes, killed pathogens, or specific recombinant subunit antigens.
    • Simulates an active microbial invasion without causing disease pathology, stimulating the host's B lymphocytes to produce specific protective antibodies and lasting memory cells.
    • Passive Artificial Immunity
    • Involves the parenteral administration of concentrated exogenous antibodies or immune globulins collected from human or animal donors to a non-immune, exposed, or at-risk patient.
    • Grants immediate systemic protection against toxins or pathogens, but because the recipient's own lymphocytes are not activated, the acquired protection is transient and degrades as the donor antibodies undergo biological catabolism.

  • Vaccines and Antitoxins

    • Therapeutic Goal: Offer acquired prophylaxis against targeted communicative infectious diseases.
    • Antitoxins: Specialized biological preparations containing high-titer antibodies designed to counteract and neutralize circulating microbial exotoxins in individuals with high-risk exposures.
    • Indicated in acute clinical exposures to conditions such as diphtheria, tetanus, or botulism where the patient's existing immune response is inadequate to prevent life-threatening toxin damage.
    • Tetanus Immune Globulin (BayTet): Confers immediate passive neutralization of circulating tetanus toxoid in unprotected, exposed wound patients.
    • Adverse Reactions Associated with Vaccines:
    • Mild local/systemic reactions: Low-grade fever, erythema, localized swelling, and tenderness at the intramuscular or subcutaneous injection site.
    • Severe systemic reactions: Acute anaphylaxis characterized by bronchospasm, laryngeal edema, cardiovascular collapse, and hypotension.

Anti-Inflammatory, Antihistaminic, and Decongestant Medications

  • Pathophysiology of Allergic Reactions

    • Allergies represent hypersensitivity immune overresponses triggered by non-pathogenic environmental antigens (allergens) that pose no intrinsic threat to the host.
    • Common Sensitizing Allergens: Plant pollens, domestic animal dander, fungal molds, mildew, dust mites, cigarette smoke, specific foods (e.g., peanuts, shellfish), and medications (e.g., penicillins).
    • Symptom Continuum: Range from mild localized discomfort (sneezing, clear rhinorrhea, nasal congestion, watery pruritic conjunctivitis) to severe systemic anaphylactic shock, a medical emergency that can rapidly culminate in fatal airway obstruction and circulatory collapse.

  • Antihistamines

    • Diphenhydramine (Benadryl)
    • Drug Class: First-generation H1 receptor antagonist/antihistamine.
    • Formulations: Oral capsules/tablets/liquids, topical creams/gels, and parenteral injections.
    • Mechanism of Action: Competitively blocks peripheral and central H1 histamine receptors, reducing histamine-mediated vascular dilation, capillary permeability, pruritus, and smooth muscle bronchospasm; exerts relaxing effects on respiratory, vascular, and gastrointestinal smooth muscle.
    • Side Effects and Adverse Reactions: Marked central nervous system depression (drowsiness, somnolence, dizziness), psychomotor impairment, confusion, and prominent anticholinergic effects including xerostomia (dry mouth), urinary retention, and blurred vision.
    • Nursing Considerations:
      • Evaluate patient sedation level and implement strict fall precautions.
      • Instruct patients to avoid ethanol and other central nervous system depressants.
      • Exercise extreme vigilance when administering to geriatric patients and individuals with pre-existing angle-closure glaucoma, prostatic hyperplasia, or chronic urinary retention.

  • Glucocorticoids / Corticosteroids

    • General Pharmacodynamics: Synthetic steroid-like compounds structurally related to endogenous cortisol; bind intracellular glucocorticoid receptors to inhibit pro-inflammatory cytokines, stabilize lysosomal membranes, and profoundly suppress cell-mediated and humoral immune cascades.
    • Indications: Management of autoimmune exacerbations, allergic emergencies, organ rejection prophylaxis, and persistent airway inflammation.
    • Fluticasone (Flovent)
    • Drug Class: Inhaled corticosteroid (ICS).
    • Mechanism of Action: Suppresses localized mucosal inflammation, microvascular exudation, and edema within the bronchial airway tree.
    • Adverse Reactions: Localized oral candidiasis (oropharyngeal thrush), dysphonia (hoarseness), and throat irritation; systemic hypothalamic-pituitary-adrenal (HPA) axis suppression may occur with sustained high-dose regimens.
    • Nursing Considerations:
      • Emphasize that fluticasone is a long-term maintenance prophylactic medication and must never be utilized as an acute rescue inhaler for active bronchospasm.
      • Educate patients on correct metered-dose inhaler or dry-powder inhaler technique.
      • Mandate that patients thoroughly rinse their mouth with water and expectorate (spit) immediately following every inhalation dose to minimize oral thrush risk.
    • Hydrocortisone (Cortef)
    • Drug Class: Systemic and topical short-acting glucocorticoid.
    • Mechanism of Action: Suppresses systemic inflammatory pathways and immune activation; functions as replacement therapy for endogenous cortisol deficiency in primary or secondary adrenal insufficiency.
    • Adverse Reactions: Hyperglycemia, secondary hypertension, fluid and sodium retention, enhanced susceptibility to systemic infections, osteoporosis, gastrointestinal ulceration, and iatrogenic adrenal suppression.
    • Nursing Considerations:
      • Monitor blood glucose levels, resting blood pressure, daily weights, fluid balance, and clinical indicators of occult infection.
      • Warn patients against abrupt discontinuation following long-term therapy; dosages must be tapered gradually under provider supervision to prevent life-threatening acute adrenal crisis.

  • Nasal Decongestants

    • General Pharmacodynamics: Sympathomimetic agents that stimulate vascular alpha-1 adrenergic receptors, provoking pronounced local vasoconstriction of swollen nasal mucosal arterioles; this action decreases blood flow, relieves mucosal congestion, and dries secretions.
    • Pseudoephedrine (Sudafed): Systemic oral sympathomimetic decongestant utilized for relief of upper respiratory mucosal congestion.
    • Oxymetazoline (Afrin): Topical nasal spray offering rapid, potent nasal decongestion.
    • Phenylephrine (Neo-Synephrine): Topical nasal spray (and oral agent) indicated for acute relief of nasopharyngeal congestion.
    • Side Effects and Adverse Reactions: Systemic sympathetic stimulation resulting in tachycardia, elevated blood pressure, cardiac palpitations, psychomotor agitation, nervousness, and insomnia.
    • Nursing Considerations:
    • Routinely assess baseline blood pressure and pulse prior to and during administration.
    • Exercise heightened caution in patients with underlying ischemic heart disease, cardiac dysrhythmias, hypertension, hyperthyroidism, or cerebrovascular disease.

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

    • General Pharmacodynamics: Non-hormonal, non-steroidal agents that possess analgesic, antipyretic, and anti-inflammatory properties.
    • Mechanism of Action: Inhibit the cyclooxygenase (COX) enzyme system, halting the biosynthesis of prostaglandins that mediate peripheral pain transduction, inflammatory edema, and hypothalamic fever regulation.
    • Ibuprofen (Advil, Motrin)
    • Drug Class: Non-selective NSAID; analgesic, antipyretic.
    • Mechanism of Action: Reversibly inhibits COX-1 and COX-2 enzymes, thereby reducing prostaglandin production.
    • Side Effects and Adverse Reactions: Gastric irritation, peptic ulceration, occult gastrointestinal hemorrhage, nephrotoxicity/acute kidney injury, fluid retention, blood pressure elevation, and increased risk of thrombotic cardiovascular events.
    • Nursing Considerations:
      • Monitor for clinical signs of gastrointestinal bleeding (melena, hematemesis, drop in hemoglobin) and assess renal panel values (BUN, serum creatinine) and blood pressure changes.
      • Administer concurrently with meals, milk, or a full glass of water to reduce gastric discomfort.
      • Advise patients not to take multiple concurrent NSAID products simultaneously.
      • Apply caution and specific clinical screening in individuals with underlying cardiovascular pathology or heart problems.
    • Naproxen (Aleve)
    • Drug Class: Non-selective propionic acid NSAID; analgesic, antipyretic.
    • Mechanism of Action: Inhibits peripheral and central prostaglandin production via non-selective COX blockade.
    • Side Effects and Adverse Reactions: Upper and lower gastrointestinal ulceration, severe gastrointestinal hemorrhage, renal impairment, fluid retention, and thrombotic cardiovascular risks.
    • Nursing Considerations:
      • Regularly assess renal function markers, baseline blood pressure, and manifestations of occult blood loss.
      • Utilize the lowest effective therapeutic dose for the shortest possible duration.
      • Explicitly instruct patients to avoid concurrent ingestion of other NSAIDs, including over-the-counter ibuprofen.

Antibacterial Medications (Antibiotics)

  • General Principles of Antibiotic Therapy

    • Antibacterial medications are selective chemotherapeutic agents indicated solely for the eradication or growth arrest of susceptible bacterial pathogens; they have zero therapeutic efficacy against viral pathogens.
    • Destruction of Endogenous Normal Flora: Systemic antibiotic use eradicates non-pathogenic commensal microbial populations in the gastrointestinal, respiratory, and vaginal tracts, frequently precipitating secondary superinfections such as oral or vaginal candidiasis (yeast infections) and Clostridioides difficile-associated diarrhea.
    • Culture and Sensitivity (C&S) Testing: Microbiological diagnostics should be obtained prior to initiating antimicrobial therapy to isolate the causative bacterial strain and identify its specific antibiotic susceptibility profile.

  • Penicillins

    • Background: One of the oldest and most widely prescribed antimicrobial drug classes; characterized by an unstable beta-lactam chemical ring structure.
    • Formulations and Routes: Available in oral tablets, oral suspensions, topical applications, and parenteral (IV/IM) formulations for common infections including streptococcal pharyngitis (strep throat) and otitis media.
    • Mechanism of Action: Inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), causing cell wall lysis and bacterial death in susceptible gram-positive and selected gram-negative microorganisms.
    • Pharmacoeconomics: Represents one of the least expensive antimicrobial classes in clinical practice.
    • Adverse Reactions: High prevalence of drug hypersensitivities ranging from mild maculopapular rash, pruritus, and urticaria to life-threatening acute anaphylaxis; severe diarrhea and C. difficile colitis.
    • Specific Agents:
    • Ampicillin (Omnipen): Broad-spectrum aminopenicillin active against gram-positive and gram-negative pathogens.
    • Amoxicillin (Amoxil): Broad-spectrum aminopenicillin; oral suspension and capsules.
      • Side Effects: Nausea, diarrhea, cutaneous rashes, hypersensitivity reactions, anaphylaxis, and C. difficile-associated diarrhea.
      • Nursing Considerations: Thoroughly review the patient's prior history for beta-lactam or penicillin hypersensitivity; observe continuously for immediate anaphylactic signs; educate the patient to complete the entire course exactly as prescribed.
    • Penicillin V Potassium (Pen VK): Acid-stable oral penicillin formulation frequently prescribed for streptococcal upper respiratory infections.

  • Cephalosporins

    • Pharmacological Profile: Chemically, structurally, and functionally related to penicillins (contain a beta-lactam ring); systematically grouped into generations based on their antimicrobial spectrum; historically more expensive than basic penicillins.
    • Cefazolin (Ancef)
    • Drug Class: First-generation cephalosporin.
    • Mechanism of Action: Inhibits bacterial cell wall synthesis; exhibits potent bactericidal activity against gram-positive cocci.
    • Clinical Use: Extensively utilized in hospital settings as parenteral surgical antimicrobial prophylaxis before surgical incision.
    • Side Effects: Hypersensitivity reactions (including potential cross-sensitivity in penicillin-allergic individuals), severe diarrhea, C. difficile colitis, and neurotoxicity manifesting as seizures.
    • Nursing Considerations: Review history for prior severe beta-lactam reactions; monitor clinical response to infection and serial renal function tests.
    • Cefepime (Maxipime)
    • Drug Class: Fourth-generation cephalosporin.
    • Spectrum: Broad-spectrum antimicrobial coverage extending across multiple resilient gram-negative bacilli, including Pseudomonas aeruginosa, as well as gram-positive pathogens.
    • Mechanism of Action: Disrupts bacterial cell wall synthesis.
    • Side Effects: Allergic reactions, severe diarrhea, C. difficile superinfection, severe encephalopathy, acute confusion, and neurotoxic seizures.
    • Nursing Considerations: Routinely monitor serum creatinine and glomerular filtration rates, ensuring individualized dosage reductions in renal insufficiency; closely observe mental status, as impaired renal clearance dramatically accelerates neurotoxic complications.

  • Tetracyclines

    • Doxycycline (Vibramycin)
    • Drug Class: Tetracycline antibiotic.
    • Mechanism of Action: Exerts bacteriostatic actions by reversibly binding the 30S ribosomal subunit, inhibiting bacterial protein synthesis.
    • Contraindications and Warnings: High binding affinity for calcium; deposits directly into developing bones and teeth, causing permanent tooth discoloration/staining (yellow-gray-brown pigmentation) and enamel hypoplasia in fetuses and growing children; strictly avoided during pregnancy, lactation, and childhood.
    • Side Effects: Severe cutaneous photosensitivity, gastrointestinal distress, and severe chemical esophagitis/esophageal ulceration.
    • Nursing Considerations:
      • Instruct the patient to take oral doses with a full glass of water (8 oz8\text{ oz}) and remain strictly upright for at least 30 minutes30\text{ minutes} post-dose to prevent esophageal lodging and ulceration.
      • Instruct patients to apply liberal sun protection and avoid direct ultraviolet/sunlight exposure.
      • Space oral doses several hours apart from metal-containing cations such as antacids, iron supplements, calcium, or dairy products to avoid chelation and therapeutic failure.
      • Verify maternal and pediatric safety status prior to dispensing.

  • Fluoroquinolones / Quinolones

    • Ciprofloxacin (Cipro)
    • Drug Class: Fluoroquinolone antibiotic.
    • Administration Routes: Intravenous infusions, ophthalmic solutions/ointments, and oral tablets/suspensions.
    • Spectrum and Uses: Highly effective in the treatment of chronic or complicated urinary tract infections; generally reserved for antimicrobial-resistant bacterial strains due to rare, debilitating toxicities.
    • Mechanism of Action: Prevents bacterial replication and growth by inhibiting bacterial DNA enzymes (topoisomerase II/DNA gyrase and topoisomerase IV).
    • Side Effects and Severe Warnings: Tendinopathy and spontaneous tendon rupture (frequently involving the Achilles tendon), peripheral neuropathy, severe central nervous system effects (agitation, hallucinations, tremors, confusion), cardiac QT interval prolongation, acute dysglycemia, and C. difficile-associated colitis.
    • Nursing Considerations:
      • Instruct the patient to instantly discontinue the medication and seek medical attention upon the earliest onset of tendon pain, inflammation, swelling, or peripheral neurological tingling.
      • Thoroughly screen current medication profile for QT-prolonging drugs and monitor renal function.
      • Separate oral administration times from divalent and trivalent cations (antacids, iron, magnesium, aluminum, mineral supplements) to ensure adequate gastrointestinal absorption.

Antifungal, Antiviral, and Antiretroviral Agents

  • Antifungal Medications
    • Pathological Indications: Indicated for systemic and superficial mycoses, including tinea pedis (athlete's foot) and candidiasis (mucocutaneous and systemic yeast infections).
    • Miconazole (Desenex)
    • Drug Class: Imidazole antifungal.
    • Formulations: Topical powders, sprays, and creams.
    • Mechanism of Action: Disrupts fungal ergosterol synthesis, inhibiting normal fungal cell membrane synthesis.
    • Side Effects: Localized dermatological stinging, burning, pruritus, irritation, and erythema.
    • Nursing Considerations: Cleanse and thoroughly dry the affected intertriginous or pedal regions before application; apply thin layers exactly as prescribed; monitor the skin surface for localized contact sensitivity.
    • Fluconazole (Diflucan)
    • Drug Class: Triazole antifungal.
    • Formulations: Oral tablets/suspensions and systemic intravenous infusions.
    • Mechanism of Action: Selectively inhibits fungal cytochrome P-450-dependent enzyme pathways, preventing fungal membrane ergosterol synthesis.     *